Revive Therapeutics Ltd (RVV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 4,115 | 4,890 | 7,150 | 4,266 | 2,643 |
| Operating Income | -4,115 | -4,890 | -7,150 | -4,266 | -2,643 |
| Interest Expense | 16 | 17 | 18 | 19 | 20 |
| Other Income | 34 | 37 | -1,683 | 17 | 187 |
| Pre-tax Income | -4,098 | -4,870 | -8,852 | -4,268 | -2,476 |
| Net Income Continuous | -4,098 | -4,870 | -8,852 | -4,268 | -2,476 |
| Net Income | $-4,098 | $-4,870 | $-8,852 | $-4,268 | $-2,476 |
| EPS Basic Total Ops | -0.01 | -0.02 | -0.03 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.02 | -0.03 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.02 | -0.03 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.02 | -0.03 | -0.01 | -0.01 |
| EBITDA(a) | $-4,081 | $-4,853 | $-8,833 | $-4,249 | $-2,456 |